Ken Griffin Procaps Group, S.A. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Procaps Group, S.A. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,500 shares of PROC stock, worth $31,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,500Holding current value
$31,374% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PROC
# of Institutions
11Shares Held
104KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA28.9KShares$72,6340.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.3KShares$63,5020.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$35,1400.64% of portfolio
-
State Street Corp Boston, MA12.4KShares$31,0310.0% of portfolio
-
Activest Wealth Management10KShares$25,0990.02% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $283M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...